Gene · 389
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A high expression ratio of RhoA/RhoB is associated with the migratory and invasive properties of basal-like Breast Tumors. | Int J Med Sci | 2020 | 33162807 | PubTator, text mining | PubMed |
| Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection. | BMC Genomics | 2020 | 33148169 | PubTator, text mining | PubMed |
| Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes. | Sci Rep | 2020 | 33139779 | PubTator, text mining | PubMed |
| Transcriptomic and Proteomic Analysis Reveals Mechanisms of Patulin-Induced Cell Toxicity in Human Embryonic Kidney Cells. | Toxins (Basel) | 2020 | 33138038 | PubTator, text mining | PubMed |
| Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility. | Breast Cancer (Dove Med Press) | 2020 | 33116817 | PubTator, text mining | PubMed |
| Role of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma and Its Therapeutic Prospect. | Onco Targets Ther | 2020 | 33116602 | PubTator, text mining | PubMed |
| The Associations of Common Genetic Susceptibility Variants with Breast Cancer in Jordanian Arabs: A Case-Control Study. | Asian Pac J Cancer Prev | 2020 | 33112566 | PubTator, text mining | PubMed |
| Naturally occurring hotspot cancer mutations in Gα13 promote oncogenic signaling. | J Biol Chem | 2020 | 33109615 | PubTator, text mining | PubMed |
| Downregulation of the ubiquitin ligase KBTBD8 prevented epithelial ovarian cancer progression. | Mol Med | 2020 | 33109073 | PubTator, text mining | PubMed |
| Induction of apoptosis and role of paclitaxel-loaded hyaluronic acid-crosslinked nanoparticles in the regulation of AKT and RhoA. | J Adv Pharm Technol Res | 2020 | 33102192 | PubTator, text mining | PubMed |
| The Physiology, Pathology, and Therapeutic Interventions for ROCK Isoforms in Diabetic Kidney Disease. | Front Pharmacol | 2020 | 33101039 | PubTator, text mining | PubMed |
| Transcriptomic profile of Pea3 family members reveal regulatory codes for axon outgrowth and neuronal connection specificity. | Sci Rep | 2020 | 33097800 | PubTator, text mining | PubMed |
| A Screen for PKN3 Substrates Reveals an Activating Phosphorylation of ARHGAP18. | Int J Mol Sci | 2020 | 33092266 | PubTator, text mining | PubMed |
| RNF180 mediates STAT3 activity by regulating the expression of RhoC via the proteasomal pathway in gastric cancer cells. | Cell Death Dis | 2020 | 33082325 | PubTator, text mining | PubMed |
| MicroRNA-340-5p inhibits colon cancer cell migration via targeting of RhoA. | Sci Rep | 2020 | 33037251 | PubTator, text mining | PubMed |
| Identification of Latent Oncogenes with a Network Embedding Method and Random Forest. | Biomed Res Int | 2020 | 33029511 | PubTator, text mining | PubMed |
| RHOAming Through the Nucleotide Excision Repair Pathway as a Mechanism of Cellular Response Against the Effects of UV Radiation. | Front Cell Dev Biol | 2020 | 33015036 | PubTator, text mining | PubMed |
| Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements. | Pharmaceutics | 2020 | 33003468 | PubTator, text mining | PubMed |
| Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells. | PLoS One | 2020 | 33002044 | PubTator, text mining | PubMed |
| MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells. | Biol Res | 2020 | 32993809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389/papers?page=38